PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
Stanford University
Novartis
ADC Therapeutics S.A.
Eli Lilly and Company
Fred Hutchinson Cancer Center
Genmab
Genmab
Nektar Therapeutics
Nektar Therapeutics
Incyte Corporation
Duke University
Calithera Biosciences, Inc
Incyte Corporation
Gilead Sciences
Incyte Corporation
Stanford University